Article
The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
17 Mar 2025
Abstract excerpt
Gene mutations in PIK3CA, the catalytic subunit of phosphoinositide 3-kinases, are significantly associated with prognosis in breast cancer. This association suggests that breast cancer patients with PIK3CA mutations should receive PIK3CA mutant-specific treatment. This review aimed to investigate novel treatments for PIK3CA-mutant breast cancer. This study investigated the effects of PIK3CA mutations in breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
